ProxiScan SPECT system wins Frost & Sullivan technology innovation award
31 Jan 2011
Hybridyne Technologies' Proxiscan SPECT imaging system has been awarded the 2010 North American Frost & Sullivan Award for Technology Innovation of the Year.
ProxiScan, recently approved by the FDA, is based on the compact cadmium-zinc-telluride (CZT) detector, which is the core enabling component for creating high resolution SPECT images.
ProxiScan is unique because it differs from traditional scintillator-based SPECT gamma cameras by offering much higher spatial resolution. It emerges as a technology that can lead to a more accurate and timely diagnosis and vastly improve upon the treatment strategies used for patients, leading to improved cancer care.
"This technology has the distinct advantages of being compact and less costly, while offering better image quality within a smaller field of view," explains Frost & Sullivan Industry Analyst Sangeetha Prabakar. "Not only does it provide effective and more accurate localization of cancer at an earlier stage, the device's compactness also allows more accurate imaging by targeting the desired imaging area."
Because of its compact design, ProxiScan can be used for trans-rectal imaging and intra-body cavity measurements, which were originally not possible with conventional gamma cameras. With ProxiScan, the working distance between the gamma camera and prostate gland is greatly minimized. This allows urologists to obtain much better images of abnormal tissue with smaller amounts of the injected radioactive tracer.
"ProxiScan's spectrometer-mode imaging capabilities, coupled with its proximity to the imaging area, greatly reduces the adverse effects of scattered radiation, allowing ProxiScan to mitigate this key issue that limits image quality," remarks Prabakar.
"The system — by being capable of producing high-fidelity pictures more clearly — detects and localizes cancerous tumours distributed throughout the regions of interest, with the potential to detect very small tumours that would be missed with other nuclear-medical imaging technologies."
Frost & Sullivan's research shows ProxiScan's underlying technology is likely to emerge as one of the best solutions for prostate cancer diagnosis and can potentially help physicians with its greater level of sensitivity and precision at a relatively lower cost. In addition, physicians could find it easier to use because of its ease of installation and ready availability in their offices.
Furthermore, since urologists currently use trans-rectal ultrasound probes, the use of Hybridyne's ProxiScan is expected to find easy acceptance among primary end users as an intra-body-cavity probe. For patients, the compact size of the system may enhance convenience and lead to overall cost reductions for prostate cancer diagnosis and treatment.
"This will have a positive impact on most stages of cancer detection and treatment, including diagnosis, assistance with image-guided biopsies, and active surveillance," notes Prabakar. "Other potential applications of ProxiScan technology include the detection and management of other diseases that could benefit from higher resolution imaging, such as breast, thyroid, brain, cervical, colorectal and uterine cancers, as well as small animal research, such as nuclear medical studies on mice and rats for drug development."
Each year, Frost & Sullivan presents this award to a company that has demonstrated excellence in the following categories: uniqueness of technology, impact on new products/applications, impact on functionality, impact on customer value and relevance of innovation to industry.
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.